1. Home
  2. WMT vs GILD Comparison

WMT vs GILD Comparison

Compare WMT & GILD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Walmart Inc.

WMT

Walmart Inc.

HOLD

Current Price

$103.64

Market Cap

878.5B

ML Signal

HOLD

Logo Gilead Sciences Inc.

GILD

Gilead Sciences Inc.

HOLD

Current Price

$146.12

Market Cap

165.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WMT
GILD
Founded
1945
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
878.5B
165.0B
IPO Year
2012
2003

Fundamental Metrics

Financial Performance
Metric
WMT
GILD
Price
$103.64
$146.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
29
18
Target Price
$133.86
$148.39
AVG Volume (30 Days)
22.8M
6.3M
Earning Date
05-21-2026
05-07-2026
Dividend Yield
0.77%
2.55%
EPS Growth
13.28
1684.21
EPS
0.67
N/A
Revenue
$713,163,000,000.00
$24,689,000,000.00
Revenue This Year
$6.02
$4.68
Revenue Next Year
$4.47
$6.04
P/E Ratio
$155.20
N/A
Revenue Growth
4.73
9.98
52 Week Low
$95.42
$108.46
52 Week High
$135.16
$157.29

Technical Indicators

Market Signals
Indicator
WMT
GILD
Relative Strength Index (RSI) 28.48 67.25
Support Level $98.88 $142.93
Resistance Level $117.19 $149.38
Average True Range (ATR) 2.33 4.26
MACD -0.80 1.23
Stochastic Oscillator 5.57 86.57

Price Performance

Historical Comparison
WMT
GILD

About WMT Walmart Inc.

Since its founding in 1962, Walmart has become the world's largest retailer, operating over 10,700 stores globally (including 4,600 namesake locations on its home turf and another 600 Sam's Club outlets) and growing its e-commerce presence, attracting 270 million customers weekly. In aggregate, the firm posted more than $713 billion in fiscal 2026 sales. Its core operations span three reporting segments: Walmart US (68% of fiscal 2026 sales), Walmart International (19%), and Sam's Club (13%).Within the US, nearly 60% of its $486 billion in fiscal 2026 revenue came from its grocery offerings, with another quarter from general merchandise. Internationally, Walmart's operations are concentrated in Mexico, though it also has budding exposure to India.

About GILD Gilead Sciences Inc.

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Share on Social Networks: